Shell Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.34M | Sell |
7,254
-8,096
| -53% | -$2.52M | 0.24% | 88 |
|
|
2025
Q2 | $5.97M | Buy |
15,350
+4,924
| +47% | +$1.98M | 0.21% | 97 |
|
|
2025
Q1 | $4.54M | Sell |
10,426
-411
| -4% | -$165K | 0.22% | 84 |
|
|
2024
Q4 | $4M | Buy |
10,837
+20
| +0.2% | +$8.37K | 0.17% | 100 |
|
|
2024
Q3 | $5.63M | Buy |
+10,817
| New | +$5.78M | 0.25% | 72 |
|
|
2024
Q1 | $5.67M | Buy |
10,460
+757
| +8% | +$376K | 0.26% | 72 |
|
|
2023
Q4 | $4.58M | Sell |
9,703
-2,142
| -18% | -$990K | 0.21% | 96 |
|
|
2023
Q3 | $5.16M | Sell |
11,845
-107
| -0.9% | -$48.5K | 0.21% | 91 |
|
|
2023
Q2 | $5.31M | Sell |
11,952
-2,161
| -15% | -$997K | 0.21% | 95 |
|
|
2023
Q1 | $6.49M | Sell |
14,113
-9
| -0.1% | -$4.28K | 0.27% | 73 |
|
|
2022
Q4 | $7.24M | Sell |
14,122
-2,120
| -13% | -$1.08M | 0.32% | 65 |
|
|
2022
Q3 | $7.38M | Sell |
16,242
-4,445
| -21% | -$2.13M | 0.29% | 66 |
|
|
2022
Q2 | $9.98M | Sell |
20,687
-4,600
| -18% | -$2.28M | 0.3% | 63 |
|
|
2022
Q1 | $12.4M | Sell |
25,287
-1,754
| -6% | -$802K | 0.29% | 66 |
|
|
2021
Q4 | $12.5M | Buy |
27,041
+2,698
| +11% | +$1.14M | 0.26% | 76 |
|
|
2021
Q3 | $9.07M | Buy |
24,343
+6,002
| +33% | +$2.28M | 0.2% | 109 |
|
|
2021
Q2 | $7M | Sell |
18,341
-1,224
| -6% | -$468K | 0.14% | 164 |
|
|
2021
Q1 | $7.02M | Sell |
19,565
-14,520
| -43% | -$4.67M | 0.14% | 170 |
|
|
2020
Q4 | $10.9M | Buy |
34,085
+5,487
| +19% | +$1.68M | 0.23% | 103 |
|
|
2020
Q3 | $7.68M | Buy |
28,598
+890
| +3% | +$239K | 0.18% | 132 |
|
|
2020
Q2 | $7.29M | Sell |
27,708
-2,624
| -9% | -$700K | 0.18% | 133 |
|
|
2020
Q1 | $6.89M | Sell |
30,332
-3,250
| -10% | -$886K | 0.19% | 131 |
|
|
2019
Q4 | $10.1M | Buy |
33,582
+1,704
| +5% | +$469K | 0.22% | 116 |
|
|
2019
Q3 | $7.65M | Buy |
31,878
+8,573
| +37% | +$2.35M | 0.17% | 143 |
|
|
2019
Q2 | $6.58M | Sell |
23,305
-907
| -4% | -$248K | 0.15% | 177 |
|
|
2019
Q1 | $6.95M | Sell |
24,212
-15,328
| -39% | -$4.43M | 0.15% | 172 |
|
|
2018
Q4 | $10.4M | Sell |
39,540
-1,632
| -4% | -$449K | 0.26% | 100 |
|
|
2018
Q3 | $11.3M | Sell |
41,172
-227
| -0.5% | -$58.9K | 0.22% | 113 |
|
|
2018
Q2 | $9.85M | Sell |
41,399
-2,311
| -5% | -$535K | 0.2% | 133 |
|
|
2018
Q1 | $9.6M | Hold |
43,710
| – | – | 0.19% | 142 |
|
|
2017
Q4 | $9.84M | Sell |
43,710
-1,085
| -2% | -$231K | 0.2% | 135 |
|
|
2017
Q3 | $8.51M | Sell |
44,795
-3,821
| -8% | -$727K | 0.19% | 152 |
|
|
2017
Q2 | $9.15M | Buy |
48,616
+493
| +1% | +$88.6K | 0.2% | 149 |
|
|
2017
Q1 | $7.96M | Buy |
48,123
+1,642
| +4% | +$261K | 0.17% | 164 |
|
|
2016
Q4 | $6.68M | Sell |
46,481
-13,462
| -22% | -$1.8M | 0.16% | 170 |
|
|
2016
Q3 | $7.51M | Buy |
+59,943
| New | +$7.74M | 0.16% | 172 |
|
|
2014
Q4 | – | Sell |
-86,410
| Closed | -$10.3M | – | 869 |
|
|
2014
Q3 | $10.3M | Buy |
86,410
+1,790
| +2% | +$205K | 0.16% | 128 |
|
|
2014
Q2 | $9.11M | Buy |
84,620
+9,697
| +13% | +$999K | 0.14% | 146 |
|
|
2014
Q1 | $7.46M | Buy |
74,923
+672
| +0.9% | +$60.8K | 0.12% | 175 |
|
|
2013
Q4 | $6.86M | Sell |
74,251
-11,393
| -13% | -$1.01M | 0.12% | 176 |
|
|
2013
Q3 | $7.16M | Sell |
85,644
-657
| -0.8% | -$56.3K | 0.13% | 175 |
|
|
2013
Q2 | $7.06M | Buy |
+86,301
| New | +$6.46M | 0.13% | 178 |
|
Other funds holding ELV
Shell Asset Management's ELV Position: Q3 2025 in Review
Shell Asset Management reduced its Elevance Health (ELV) stake by 53% in Q3 2025, selling an estimated $2.52M and leaving 7,254 shares worth $2.34M. The position accounts for 0.24% of the portfolio, ranked #88.
Shell Asset Management first reported a position in ELV in Q2 2013 and has held it in 42 quarters since. The position peaked at $12.5M in Q4 2021. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Shell Asset Management held 7,254 shares of Elevance Health worth $2.34M as of Q3 2025.
- Shell Asset Management sold 8,096 Elevance Health shares in Q3 2025, an estimated $2.52M.
- Elevance Health made up 0.24% of Shell Asset Management's portfolio in Q3 2025, its #88 holding.
- Shell Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 42 quarters since.
- Shell Asset Management's Elevance Health position peaked at $12.5M in Q4 2021.
- 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.